|
|
 |
|
| |
HOME > ¿¬±¸È°µ¿ > ¿¬±¸È°µ¿ ¹× ¼º°ú |
|
 |
|
| ¿¬±¸ºÐ¾ß |
Target/Disease |
¼º°ú/Ȱµ¿ |
|
|
|
|
|
¼øÈ¯±â°èÁúȯ |
|
Anti-Arrhythmic agent |
|
ƯÇãµî·Ï 5°Ç, Ãâ¿ø 5°Ç, ÀüÀÓ»ó ÀÌÇà |
|
|
|
Anti-Thrombotic agent |
|
ƯÇãµî·Ï 8°Ç, Ãâ¿ø 5°Ç |
|
Ç×¾Ï/Ç׿°ÁõÁ¦ |
|
Breast Cancer |
|
ƯÇã Ãâ¿ø 50°Ç, ±Ç¸®¾çµµ |
| Cell cycle regulator |
|
ƯÇã Ãâ¿ø 2°Ç |
| COPD |
|
ƯÇã Ãâ¿ø 4°Ç |
|
»ýȰ½À°üÁúȯ |
|
Irritable Bowel Syndrome |
|
ƯÇãÃâ¿ø 2°Ç, ±Ç¸®¾çµµ |
|
|
|
Metabolic disease |
|
¿¬±¸ÁøÇà |
|
Ç×¾Ï/Ç׿°ÁõÁ¦ |
|
Cell cycle regulator |
|
Áß¿Ü/Áê°¡ÀÌ °úÁ¦ °øµ¿¿¬±¸ |
| Kinase inhibitors |
|
| Transcription factor inhibitor |
|
| |
|
|
°ñ/´ë»çÁúȯ |
|
Osteoporosis |
|
|
|
|
Diabetes |
|
|
|
|
|
|
|
|
|